Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Colorcon
Daiichi Sankyo
Baxter
Boehringer Ingelheim
Johnson and Johnson

Generated: July 20, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018297

Try a free trialSee Plans and Pricing

« Back to Dashboard

NDA 018297 describes LOPURIN, which is a drug marketed by Abbott and Dr Reddys La and is included in three NDAs. It is available from four suppliers. Additional details are available on the LOPURIN profile page.

The generic ingredient in LOPURIN is allopurinol. There are twenty-two drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the allopurinol profile page.
Summary for 018297
Tradename:LOPURIN
Applicant:Abbott
Ingredient:allopurinol
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 018297

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength100MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength300MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired US Patents for NDA 018297

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott LOPURIN allopurinol TABLET;ORAL 018297-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Abbott LOPURIN allopurinol TABLET;ORAL 018297-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
McKinsey
McKesson
UBS
Federal Trade Commission
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.